Russell Investments Group
APLT

Russell Investments Group’s Applied Therapeutics APLT Stock Holding History

Russell Investments Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,648
Closed -$18.5K – 3796
2024
Q4 		$18.5K Sell
21,648
-60,632
-74% -$380K ﹤0.01% 3026
2024
Q3 		$699K Buy
+82,280
New +$485K ﹤0.01% 2165
2022
Q1 		– Sell
-75,800
Closed -$677K – 2741
2021
Q4 		$677K Buy
75,800
+21,419
+39% +$281K ﹤0.01% 2330
2021
Q3 		$901K Hold
54,381
– – ﹤0.01% 2234
2021
Q2 		$1.13M Buy
+54,381
New +$1.03M ﹤0.01% 2255

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group's APLT Position: Q1 2025 in Review

Russell Investments Group sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 21,648 shares — an estimated $18.5K sold.

Russell Investments Group first reported a position in APLT in Q2 2021 and held it in 5 quarters. The position peaked at $1.13M in Q2 2021. 90 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • Russell Investments Group reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 21,648 Applied Therapeutics shares in Q1 2025, an estimated $18.5K.
  • Russell Investments Group first reported a position in Applied Therapeutics in Q2 2021 and held it in 5 quarters.
  • Russell Investments Group's Applied Therapeutics position peaked at $1.13M in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.